Treatment of pharmacophobia consists of a combination of psychotherapy, pharmacotherapy, and multidisciplinary support to ensure comprehensive, tailored care. Psychotherapy options include cognitive behavioral therapy (CBT) and exposure therapy. CBT is a specific method that integrates talk therapy to help affected individuals address and manage problematic patterns of thinking. CBT usually requires multiple sessions with a psychotherapist or psychiatrist, who helps the affected individual gain a deeper understanding of the underlying problem and recognize problematic thoughts and behaviors related to identified triggers. Exposure therapy is another form of talk therapy in which the individual is gradually exposed to the trigger. During exposure therapy, a therapist creates a safe environment and gradually exposes the individuals to feared objects and situations.
Pharmacotherapy includes selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine and citalopram, which can be used in conjunction with psychotherapy for individuals with more severe symptoms. To control a heightened episode of anxiety, a benzodiazepine medication (e.g., alprazolam, clonazepam) may be useful. However, an individual’s underlying fear may pose a challenge to medication adherence. When the individual takes medications without overwhelming fear, medical professionals can acknowledge improvement and emphasize or reinforce good news related to the lack of adverse outcomes related to medication use. Altogether, a multidisciplinary team of psychiatrists and mental health professionals can help manage pharmacophobia.
